2017 - Fellow of the American Association for the Advancement of Science (AAAS)
2016 - Fellow, National Academy of Inventors
Transforming growth factor, Cell biology, Transforming growth factor beta, Molecular biology and Cancer research are his primary areas of study. His Transforming growth factor research incorporates themes from Cell culture, Epidermal growth factor, Biochemistry, Cell growth and Growth factor. His Cell biology study combines topics in areas such as Endocrinology, Internal medicine, Platelet-derived growth factor receptor and Cellular differentiation.
The various areas that he examines in his Transforming growth factor beta study include Epithelial–mesenchymal transition, Tumor microenvironment, Fibronectin, Transforming growth factor, beta 3 and Adenocarcinoma. His work deals with themes such as Trypsin, Keratinocyte, TGF beta signaling pathway, Receptor and Platelet, which intersect with Molecular biology. The Cancer research study combines topics in areas such as Mammary tumor, Carcinogenesis, Immunology, Metastasis and Tumor progression.
Harold L. Moses mostly deals with Transforming growth factor, Cancer research, Cell biology, Transforming growth factor beta and Internal medicine. His Transforming growth factor research integrates issues from Cell culture, Epidermal growth factor, Cell growth, Molecular biology and Transforming growth factor, beta 3. His work carried out in the field of Cancer research brings together such families of science as Tumor progression, Cancer and Metastasis.
His study looks at the relationship between Cell biology and fields such as Autocrine signalling, as well as how they intersect with chemical problems. His studies link Cellular differentiation with Transforming growth factor beta. His Internal medicine research includes elements of Endocrinology and Oncology.
Harold L. Moses focuses on Cancer research, Tumor microenvironment, Internal medicine, Cancer and Pathology. His research in Cancer research intersects with topics in Tumor progression, Metastasis, Mammary tumor and Transforming growth factor. He studies Transforming growth factor beta, a branch of Transforming growth factor.
Harold L. Moses interconnects Gastroenterology, Endocrinology, Physical therapy and Oncology in the investigation of issues within Internal medicine. His studies in Cancer integrate themes in fields like Antibody and Immunology. His Pathology research is multidisciplinary, incorporating perspectives in Cancer cell, Colorectal cancer, Laser capture microdissection and Cell growth.
Harold L. Moses mainly focuses on Cancer research, Tumor microenvironment, Stromal cell, Transforming growth factor and Tumor progression. His Cancer research study incorporates themes from Cancer, Metastasis, Endocrinology, Immunology and Transforming growth factor beta. His research investigates the connection with Endocrinology and areas like Cellular differentiation which intersect with concerns in Internal medicine, Prostate, Lewis lung carcinoma and Molecular biology.
His Transforming growth factor beta research includes themes of Epithelial–mesenchymal transition, Cell migration and Carcinogenesis. In his study, Receptor and Cancer cell is inextricably linked to Cell, which falls within the broad field of Transforming growth factor. His studies deal with areas such as TGF beta signaling pathway and Cell type as well as Signal transduction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Stromal fibroblasts in cancer initiation and progression
Neil A. Bhowmick;Eric G. Neilson;Harold L. Moses.
Nature (2004)
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Neil A. Bhowmick;Anna Chytil;David Plieth;Agnieszka E. Gorska.
Science (2004)
Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer
Brian Bierie;Harold L. Moses.
Nature Reviews Cancer (2006)
Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival.
Berna C. Özdemir;Berna C. Özdemir;Tsvetelina Pentcheva-Hoang;Julienne L. Carstens;Xiaofeng Zheng.
Cancer Cell (2014)
TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights
Harold L. Moses;Edmund Y. Yang;Jennifer A. Pietenpol.
Cell (1990)
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
R M Lyons;J Keski-Oja;H L Moses.
Journal of Cell Biology (1988)
Transforming Growth Factor-β1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism
Neil A. Bhowmick;Mayshan Ghiassi;Andrei Bakin;Mary Aakre.
Molecular Biology of the Cell (2001)
Growth Factors and Cancer
Anton Scott Goustin;Edward B. Leof;Gary D. Shipley;Harold L. Moses.
Cancer Research (1986)
Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration
Andrei V. Bakin;Anne K. Tomlinson;Neil A. Bhowmick;Harold L. Moses.
Journal of Biological Chemistry (2000)
Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta.
A E Postlethwaite;J Keski-Oja;H L Moses;A H Kang.
Journal of Experimental Medicine (1987)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Vanderbilt University Medical Center
Vanderbilt University Medical Center
University of Helsinki
Vanderbilt University Medical Center
University of Tokyo
The University of Texas Southwestern Medical Center
University of California, San Francisco
University of Tokyo
Vanderbilt University Medical Center
University of California, San Francisco
Rutgers, The State University of New Jersey
University of Bologna
Chinese Academy of Sciences
University of Southern Denmark
University of Groningen
University of Copenhagen
University of Montreal
University of California, San Francisco
Radboud University Nijmegen
University of Kentucky
Harokopio University
University of Liverpool
University of Geneva
University of California, Berkeley
University of Glasgow
Children's Hospital of Los Angeles